Avalo Therapeutics Inc (AVTX)

NASDAQ · Biotechnology

19.96
+0.01 (+0.05%)
Updated Aug 18, 5:18 PM ET
AI Rating
Hold
Overall Score
62
Trend
68
Momentum
80
Risk
28

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Feb 23, 2026 120 sessions Aug 14, 2026

AI Analysis

Avalo Therapeutics Inc is trading at $19.96, up 0.05% on the session. The 50 day average sits at $17.58 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 56.8, which reads as strong, and MACD is bullish crossover. Volume is below average.

The nearest support is around $17.64 with resistance near $19.83, so that band frames the current range. Average daily movement is roughly $1.19, or about 6.0% of the share price, which is what any stop placement has to allow for. The overall health score of 62 out of 100 combines a trend score of 68, momentum of 80 and a risk score of 28.

Technical indicators

RSI (14)
56.8
strong
MACD
0.397
bullish crossover
SMA 20
18.89
SMA 50
17.58
SMA 200
--
unknown
ATR (14)
1.19
avg daily range
Support
17.64
Resistance
19.83
Volume vs 20d
0.48x
below average
Volatility
60.2%
annualised
1 month
+5.61%
3 months
-1.31%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.